GNC Holdings reached an agreement with Harbin Pharmaceutical Group for a joint venture in China. Concurrently, GNC is amending its credit facility agented by JPMorgan to extend the maturity date of the term loan and add a new $100 million ABL revolver and a $275 million ABL term loan.